Prevalence of Metabolic Syndrome in Adult Population in Afghanistan
DOI:
https://doi.org/10.56101/rimj.v4i1.156Keywords:
Metabolic syndrome , Obesity, Blood pressure , Diabetes, AfghanistanAbstract
Background: After great change in governing of Afghanistan in 2001 the country is experiencing the double burden of communicable and noncommunicable diseases. In this paper, we estimated the prevalence of the Metabolic Syndrome (MetS) and its components among Afghan adults’ citizens using data from the first WHO STEP survey.
Methods: This was a cross-sectional study of adults’ individuals of ≥ 25 years in five main cities of Afghanistan including Jalalabad, Mazar Sharif, Kandahar, Herat and in Kabul during 2012 to 2015. The study was conducted in accordance with the STEPwise approach of the World Health Organization. Prevalence of metabolic syndrome, its components and associated risk factors were calculated using Adult Treatment Panel (ATP) III criteria modified for Asian in habitants. Data management, analysis and statistical procedures conducted using Epi info v. 7 and SPSS v. 20.
Results: Totally 5897 adult citizens were enrolled in this study. The average age of study subjects 39.56±12.29 years, consisting of 3185 females (54%) and 2712 males (46%). Generally, 62% of participants were illiterate and majority (82.5%) were married. The prevalence of smoking cigarettes and using mouth snuff was 8% and 11.1% and this proportion were very low in females (2.7% and 2.5%) than males (14.1% and 21.1%); this difference was statistically significant (p value=<0.01). The overall prevalence of metabolic syndrome was 39.69% (95%CI: 38.42 – 40.97). The highest rate (52.70%) was recorded in Jalalabad and lowest rate (34.11%) in Herat cities. Moderate physical activity had a statistically significant association with syndrome (OR=1.16; 95%CI:1.031-1.306).
Conclusion: Despite of struggling to control communicable diseases the country is faced with challenge of noncommunicable diseases, if the MetS is counted as a typical model. It warrants formulated public health measures to prevent morbidity and mortality due to noncommunicable disease in the future.
References
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486–2497, 2001
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539–553.
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143–3421.
Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: A new worldwide definition. Lancet 2005; 366: 1059–1062.
Lak KL, Helm MC, Kindel TL, Gould JC. Metabolic syndrome is a significant predictor of postoperative morbidity and mortality following bariatric surgery. Journal of Gastrointestinal Surgery. 2019 Apr 15; 23:739-44.
Greenfield DM, Snowden JA. Cardiovascular diseases and metabolic syndrome. The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies. 2019:415-20.
Stanciu S, Rusu E, Miricescu D, Radu AC, Axinia B, Vrabie AM, Ionescu R, Jinga M, Sirbu CA. Links between Metabolic Syndrome and Hypertension: The Relationship with the Current Antidiabetic Drugs. Metabolites. 2023 Jan 5;13(1):87.
Hirode G, Wong RJ. Trends in the prevalence of metabolic syndrome in the United States, 2011-2016. Jama. 2020 Jun 23;323(24):2526-8.
Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: A summary of the evidence. Diabetes Care. 2005; 28:1769–78.
Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation. 2003; 108:414–9.
Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S, Marini F, et al. The metabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Prospective data from the verona diabetes complications study. Diabetic Medi. 2004; 21:52–8.
Ervin RB. (2009). Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003–2006. Natl Health Stat Report, (13):1–7.
Hu G, Qiao Q, Tuomilehto J, et al. (2004). Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med, 164 (10):1066–76.
Nestel P, Lyu R, Low LP, et al. (2007). Metabolic syndrome: recent prevalence in East and Southeast Asian populations. Asia Pac J Clin Nutr, 16 (2):362–7. Iravani S, Sabayan B, Sedaghat S, et al. (2010). The association of elevated Serum Alanine aminotransferase with metabolic syndrome in a military population in Southern Iran. Iran Cardiovasc Res J, 4 (2):74–80.
Sarrafzadegan N, Kelishadi R, Baghaei A, et al. (2008). Metabolic syndrome: An emerging public health problem in Iranian Women: Isfahan Healthy Heart Program. Int J Cardiol, 131 (1):90–6.
Azizi F, Salehi P, Etemadi A, et al. (2003). Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract, 61 (1):29–37.
Delavari A, Forouzanfar MH, Alikhani S, et al. (2009). First Nationwide Study of the Prevalence of the Metabolic Syndrome and Optimal Cutoff Points of Waist Circumference in the Middle East. Diabetes Care, 32 (6):1092–97.
Fatahi A, Doosti-Irani A, Cheraghi Z. Prevalence and incidence of metabolic syndrome in Iran: a systematic review and meta-analysis. International journal of preventive medicine. 2020;11.
Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. Metabolic syndrome in urban Asian Indian adults—A population study using modified ATP III criteria Diabetes Res Clin Pract. 2003; 60:199–204
Hydrie MZ, Shera AS, Fawwad A, Basit A, Hussain A. Prevalence of metabolic syndrome in urban Pakistan (Karachi): Comparison of newly proposed International Diabetes Federation and Modified Adult Treatment Panel III criteria Metab Syndr Relat Disord. 2009; 7:119–24
Basit A, Shera AS. Prevalence of metabolic syndrome in Pakistan. Metabolic syndrome and related disorders. 2008 Sep 1;6(3):171-5.
van Namen M, Prendergast L, Peiris C. Supervised lifestyle intervention for people with metabolic syndrome improves outcomes and reduces individual risk factors of metabolic syndrome: a systematic review and meta-analysis. Metabolism. 2019 Dec 1; 101:153988.
Costa FF, Rosário WR, Farias AC, de Souza RG, Gondim RS, Barroso WA. Metabolic syndrome and COVID-19: An update on the associated comorbidities and proposed therapies. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020 Sep 1;14(5):809-14.
Syukri M, Virnardo R, Salwani D, Sofyan H. The prevalence and associated factors of metabolic syndrome among patients with end-stage renal failure undergoing hemodialysis in Indonesia. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020 Nov 1;14(6):2069-72.
Saeed KM, Rasooly MH, Nejaby M. Profile of risk factors for noncommunicable diseases in major cities of Afghanistan: WHO STEPwise approach. Eastern Mediterranean Health Journal. 2020;26(4):388-99.
Bonita R, deCourten M, Dwyer T, Jamrozik K, Winkelmann R. Surveillance of risk factors for noncommunicable diseases: the WHO STEP-wise approach. Geneva: World Health Organization; 2002 (WHO/NMH/CCS/01.2002).
Misra A, Wasir JS, Pandey RM. An evaluation of candidate definitions of the metabolic syndrome in adult Asian Indians. Diabetes Care. 2005;28(2):398–403. doi:10.2337/diacare.28.2.398 15677799
Aalemi AK, Bahain MB, Hamdard AG. Metabolic Syndrome and Psoriasis: A Case–Control Study in Kabul, Afghanistan. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021 Mar 30:1465-71.
Saeed KM, Rasooly MH, Brown NJ. Prevalence and predictors of adult hypertension in Kabul, Afghanistan. BMC Public Health. 2014 Dec;14(1):1-7.
Saeed KM. Prevalence of hypertension and associated factors in Jalalabad City, Nangarhar Province, Afghanistan. Central Asian journal of global health. 2015;4(1).
Akhtar S, Nasir JA, Javed A, Saleem M, Sajjad S, Khan M, Wadood A, Saeed K. The prevalence of diabetes in Afghanistan: a systematic review and meta-analysis. BMC public health. 2021 Dec; 21:1-8.
Taherifard E, Moradian MJ, Taherifard E, Hemmati A, Rastegarfar B, Molavi Vardanjani H. The prevalence of risk factors associated with non-communicable diseases in Afghan refugees in southern Iran: a cross-sectional study. BMC Public Health. 2021 Dec; 21:1-7.
Pengpid S, Peltzer K. Underweight and overweight/obesity among adults in Afghanistan: prevalence and correlates from a national survey in 2018. Journal of Health, Population and Nutrition. 2021 Dec;40(1):1-8.
Saeed KM. Prevalence and associated risk factors for obesity in Jalalabad city–Afghanistan. Alexandria Journal of Medicine. 2015;51(4):347-52.
Noshad S, Abbasi M, Etemad K, Meysamie A, Afarideh M, Khajeh et al. Prevalence of metabolic syndrome in Iran: A 2011 update. Journal of diabetes. 2017 May;9(5):518-25.
Naghipour M, Joukar F, Nikbakht HA, Hassanipour S, Asgharnezhad M, Arab-Zozani M, Mansour-Ghanaei F. High prevalence of metabolic syndrome and its related demographic factors in North of Iran: results from the Persian Guilan cohort study. International Journal of Endocrinology. 2021 Mar 30;2021.
Al-Rubeaan K, Bawazeer N, Al Farsi Y, Youssef AM, Al-Yahya AA, AlQumaidi H, Al-Malki BM, Naji KA, Al-Shehri K, Al Rumaih FI. Prevalence of metabolic syndrome in Saudi Arabia-a cross sectional study. BMC endocrine disorders. 2018 Dec;18:1-9.
Khader Y, Bateiha A, El-Khateeb M, Al-Shaikh A, Ajlouni K. High prevalence of the metabolic syndrome among northern Jordanians. J Diabetes Complicat. 2007; 21:214–9.
Ajlouni K, Khader Y, Alyousfi M, Al Nsour M, Batieha A, Jaddou H. Metabolic syndrome amongst adults in Jordan: prevalence, trend, and its association with socio-demographic characteristics. Diabetology & Metabolic Syndrome. 2020 Dec;12(1):1-1.
Al-Shaibani H, El-Batish M, Sorkhou I, Al-Shamali N, Al-Namash H, Habiba S, et al. Prevalence of insulin resistance syndrome in a primary health care center in Kuwait. Fam Med. 2004; 36:540.
Aryal N, Wasti SP. The prevalence of metabolic syndrome in South Asia: a systematic review. Int J Diabetes Dev Ctries. 2016; http://doi.org/10.1007/s13410-015-0365-5.
El-Aty MA, Mabry R, Morsi M, Al-Lawati J, Al-Riyami A, El-Sayed M. Metabolic syndrome and Its Components: Secondary analysis of the World Health Survey, Oman. Sultan Qaboos Univ Med J. 2014;14(4): e460-7.
Allal-Elasmi M, Taieb SH, Hsairi M, Zayani Y, Omar S, Sanhaji H, et al. The metabolic syndrome: prevalence, main characteristics and association with socio-economic status in adults living in Great Tunis. Diabetes Metab. 2010;36(3):204–8.
Almikhafy A, Maklady F, Sobhy S, Elsheikh E, Alansi AK. Metabolic syndrome among Yemeni Psysicians in Sana’a. SCU-MJ. 2008; 11:31–4.
Boden G, Chen X, DeSantis RA, Kendrick Z. Effects of age and body fat on insulin resistance in healthy men. Diabetes Care. 1993; 16:728–33.
El Brini O, Akhouayri O, Gamal A, Mesfioui A, Benazzouz B. Prevalence of metabolic syndrome and its components based on a harmonious definition among adults in Morocco. Diabetes, metabolic syndrome and obesity: targets and therapy. 2014 Jul 31:341-6.
Esmailnasab N, Moradi G, Delaveri A. Risk factors of non-communicable diseases and metabolic syndrome. Iranian Journal of Public Health. 2012;41(7):77.
Prasad DS, Kabir Z, Dash AK, Das BC. Prevalence and risk factors for metabolic syndrome in Asian Indians: A community study from urban Eastern India. J Cardiovasc Dis Res. 2012; 3: 204±211. https://doi.org/10.4103/0975-3583.98895 PMID: 22923938
Rashidi H, Payami SP, Latifi SM, Karandish M, Moravej Aleali A, Aminzadeh M, Riahi K, Ghasemi M. Prevalence of metabolic syndrome and its correlated factors among children and adolescents of Ahvaz aged 10–19. Journal of Diabetes & Metabolic Disorders. 2014 Dec;13:1-6.
Sonnenberg L, Pencina M, Kimokoti R, Quatromoni P, Nam BH, D'agostino R, Meigs JB, Ordovas J, Cobain M, Millen B. Dietary patterns and the metabolic syndrome in obese and non‐obese Framingham women. Obesity research. 2005 Jan;13(1):153-62.
Kim MH, Kim MK, Choi BY, Shin YJ. Educational disparities in the metabolic syndrome in a rapidly changing society–the case of South Korea. Int J Epidemiol. 2005; 34:1266–73.
Khosravi-Boroujeni H, Sarrafzadegan N, Sadeghi M, Roohafza H, Talaei M, Ng SK, Phung H, Pourmogaddas A, Ahmed F. Secular trend of metabolic syndrome and its components in a cohort of Iranian adults from 2001 to 2013. Metabolic syndrome and related disorders. 2017 Apr 1;15(3):137-44.
Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract. 2014; https://doi.org/10.1155/2014/943162.
Mabry RM, Reeves MM, Eakin EG, Owen N. Gender differences in prevalence of the metabolic syndrome in gulf cooperation council countries: a systematic review. Diabet Med. 2010; 27:593–7.
Atasi M, Kammar-García A, Almendra-Pegueros R, Navarro-Cruz AR. Dietary Patterns and Their Association with Metabolic Syndrome and Their Components in Middle-Class Adults from Damascus, Syria: A Cross-Sectional Study. Journal of Nutrition and Metabolism. 2022 Mar 24;2022.
Fakhrzadeh H, Ebrahimpour P, Pourebrahim R, Heshmat R, Larijani B. Metabolic Syndrome and its Associated Risk Factors in Healthy Adults: APopulation-Based Study in Iran. Metabolic syndrome and related disorders. 2006 Mar 1;4(1):28-34.
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Khwaja Mir Islam Saeed, Tajmalook Samim, Ahmad Farshid Muhammadi
This work is licensed under a Creative Commons Attribution 4.0 International License.
